Metsera Inc., a clinical-stage biopharmaceutical company focused on developing medicines for obesity and metabolic diseases, will be presenting at the Goldman Sachs 46th Annual Global Healthcare Conference. The presentation by CEO Whit Bernard is scheduled for June 11, 2025, from 10:00 to 10:35 A.M. EDT. A live webcast and replay of the presentation will be accessible on the Metsera website.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.